4

OWNERSHIP DOCUMENT

Company: CRESCENT BIOPHARMA, INC.
Filed: July 16, 2025
Period of Report: July 16, 2025
Accession Number: 0001104659-25-068426

View Document ↗ View on SEC.gov ↗